Eton Pharmaceuticals, Inc.
ETONNASDAQHealthcare● Active
$29.95
+$0.82(+2.81%)
Market Cap$820401122
P/E Ratio—
52W High$35.66
52W Low$13.09
Eton Pharmaceuticals, Inc. (ETON) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ETON · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $79.95M | $39.01M | $31.64M | $21.25M | $21.83M |
| Cost of Revenue | $37.21M | $15.60M | $10.58M | $6.93M | $2.62M |
| Gross Profit | $42.74M | $23.41M | $21.06M | $14.32M | $19.21M |
| Gross Margin %(computed) | 53.46% | 60.01% | 66.56% | 67.38% | 87.99% |
| Operating Expenses | |||||
| R&D Expenses | $7.76M | $3.25M | $3.32M | $4.00M | $6.24M |
| G&A Expenses | $35.82M | $22.75M | $18.93M | $18.58M | $14.47M |
| Total Operating Expenses | $42.67M | $26.01M | $22.25M | $22.58M | $20.70M |
| Operating Income | $0.07M | ($2.60M) | ($1.19M) | ($8.26M) | ($1.50M) |
| Operating Margin %(computed) | 0.09% | -6.66% | -3.77% | -38.87% | -6.85% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $4.78M | $2.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($4.56M) | ($3.81M) | ($0.69M) | ($9.02M) | ($1.96M) |
| Income Tax Expense | $0.04M | $0.01M | $0.25M | $0.00M | $0.00M |
| Net Income | ($4.60M) | ($3.82M) | ($0.94M) | ($9.02M) | ($1.96M) |
| Net Margin %(computed) | -5.75% | -9.80% | -2.96% | -42.45% | -8.95% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.17 | $-0.15 | $-0.04 | $-0.36 | $-0.08 |
| Wtd Avg Shares | 26.91M | 25.89M | 25.64M | 25.15M | 25.21M |
| EBITDA | $4.12M | ($1.45M) | ($0.29M) | ($6.49M) | ($1.03M) |
| EBITDA Margin %(computed) | 5.15% | -3.72% | -0.92% | -30.52% | -4.73% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Eton Pharmaceuticals, Inc. data
About Eton Pharmaceuticals, Inc. (ETON) Income Statement
Eton Pharmaceuticals, Inc. (ETON) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ETON reported revenue of $0.08B, gross profit of $0.04B (gross margin 53.46%), and net income of ($0.00B) — a net profit margin of -5.75%.
Frequently asked questions
ETON · 4 questionsEton Pharmaceuticals, Inc. (ETON) reported revenue of $0.08B for 2025, up 104.9% year-over-year.
ETON revenueETON salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08